FR2318644A1 - Nouveaux fluoteroides, leur application en tant que medicaments et leur procede de preparation - Google Patents
Nouveaux fluoteroides, leur application en tant que medicaments et leur procede de preparationInfo
- Publication number
- FR2318644A1 FR2318644A1 FR7622212A FR7622212A FR2318644A1 FR 2318644 A1 FR2318644 A1 FR 2318644A1 FR 7622212 A FR7622212 A FR 7622212A FR 7622212 A FR7622212 A FR 7622212A FR 2318644 A1 FR2318644 A1 FR 2318644A1
- Authority
- FR
- France
- Prior art keywords
- fluoteroids
- new
- application
- preparation process
- medicinal products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/009—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH962075A CH611631A5 (en) | 1975-07-23 | 1975-07-23 | Process for the preparation of 11,12-unsaturated 9alpha-fluorosteroids |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2318644A1 true FR2318644A1 (fr) | 1977-02-18 |
FR2318644B1 FR2318644B1 (xx) | 1978-12-15 |
Family
ID=4353884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7622212A Granted FR2318644A1 (fr) | 1975-07-23 | 1976-07-21 | Nouveaux fluoteroides, leur application en tant que medicaments et leur procede de preparation |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5214761A (xx) |
AT (1) | AT353989B (xx) |
AU (1) | AU505846B2 (xx) |
BE (1) | BE844378A (xx) |
CH (1) | CH611631A5 (xx) |
DE (1) | DE2632550A1 (xx) |
DK (1) | DK329976A (xx) |
ES (1) | ES449989A1 (xx) |
FR (1) | FR2318644A1 (xx) |
GB (1) | GB1520356A (xx) |
IE (1) | IE43926B1 (xx) |
NL (1) | NL7608141A (xx) |
NZ (1) | NZ181538A (xx) |
SE (1) | SE7608369L (xx) |
ZA (1) | ZA764405B (xx) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0030615B1 (en) * | 1979-11-16 | 1984-08-29 | STEROSYNT Ltd. | 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5423643A (en) * | 1977-07-22 | 1979-02-22 | Aikawa Tekko | Doctor blade stablizing apparatus |
FI911202A (fi) * | 1990-12-28 | 1992-06-29 | Albany Int Corp | Schaberblad. |
-
1975
- 1975-07-23 CH CH962075A patent/CH611631A5/xx not_active IP Right Cessation
-
1976
- 1976-07-20 DE DE19762632550 patent/DE2632550A1/de active Pending
- 1976-07-21 FR FR7622212A patent/FR2318644A1/fr active Granted
- 1976-07-21 ES ES449989A patent/ES449989A1/es not_active Expired
- 1976-07-22 ZA ZA764405A patent/ZA764405B/xx unknown
- 1976-07-22 GB GB30616/76A patent/GB1520356A/en not_active Expired
- 1976-07-22 AU AU16121/76A patent/AU505846B2/en not_active Expired
- 1976-07-22 IE IE1623/76A patent/IE43926B1/en unknown
- 1976-07-22 AT AT539376A patent/AT353989B/de not_active IP Right Cessation
- 1976-07-22 SE SE7608369A patent/SE7608369L/xx unknown
- 1976-07-22 DK DK329976A patent/DK329976A/da unknown
- 1976-07-22 NZ NZ181538A patent/NZ181538A/xx unknown
- 1976-07-22 NL NL7608141A patent/NL7608141A/xx not_active Application Discontinuation
- 1976-07-22 BE BE169116A patent/BE844378A/xx unknown
- 1976-07-23 JP JP51087371A patent/JPS5214761A/ja active Pending
Non-Patent Citations (1)
Title |
---|
NEANT * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0030615B1 (en) * | 1979-11-16 | 1984-08-29 | STEROSYNT Ltd. | 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them |
Also Published As
Publication number | Publication date |
---|---|
IE43926B1 (en) | 1981-07-01 |
NZ181538A (en) | 1978-09-20 |
NL7608141A (nl) | 1977-01-25 |
FR2318644B1 (xx) | 1978-12-15 |
JPS5214761A (en) | 1977-02-03 |
AT353989B (de) | 1979-12-10 |
AU505846B2 (en) | 1979-12-06 |
BE844378A (fr) | 1977-01-24 |
GB1520356A (en) | 1978-08-09 |
DE2632550A1 (de) | 1977-02-10 |
IE43926L (en) | 1977-01-23 |
AU1612176A (en) | 1978-01-26 |
DK329976A (da) | 1977-01-24 |
ES449989A1 (es) | 1977-12-01 |
ZA764405B (en) | 1977-08-31 |
CH611631A5 (en) | 1979-06-15 |
SE7608369L (sv) | 1977-01-24 |
ATA539376A (de) | 1979-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2337718A1 (fr) | Nouveaux hydroxy-benzodiheterocycles etherifies, leur procede de preparation et leur application en tant que medicaments | |
FR2329266A1 (fr) | Nouveaux amino-benzamides, leur preparation et leur utilisation en tant que medicaments | |
BE849542A (fr) | Nouveaux derives de quinazolone, leur preparation et leur utilisation en tant en tant que medicaments | |
BE781879A (fr) | Nouveaux 1,4-dihydropyridines dissymetriques leur procede de preparation et leur application comme medicaments | |
FR2282893A1 (fr) | Derives de thienothiazine utiles en tant que medicaments et leur procede de preparation | |
FR2340330A1 (fr) | Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments | |
FR2285864B1 (fr) | Nouveaux derives polyeniques, leur procede de preparation et leur application en tant que medicaments | |
FR2321884A1 (fr) | Nouvelles oxazolidinones-(2), leur procede de preparation et leur application en tant que medicaments | |
MC1223A1 (fr) | Nouveaux derives de 2-imino-imidazolidine,leur preparation et leur application en tant que medicaments | |
FR2351993A1 (fr) | Composes 9-(3-o-acyl-b-d-arabinofuranosyl)adeniniques, composes 9-(2,3-di-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation, et leur application en tant que medicaments | |
FR2351995A1 (fr) | Composes 9-(2-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation et leur application en tant que medicaments | |
FR2285870A1 (fr) | Nouveaux derives de benzofurane, leur procede de preparation et leur application en tant que medicaments | |
FR2294708A1 (fr) | Nouvelles 3-fluoro-2,3-dihydro-1h-1,4-benzodiazepine-2-ones, utiles en tant que medicaments et leur procede de preparation | |
BE847861A (fr) | Nouveaux amino-benzamides, leur preparation et leur utilisation en tant que medicaments | |
BE845320A (fr) | Nouveaux acides 7beta-(d-2-amino-2-(alcoyl inferieur-sulfonylamino-phenyl) -acetylamino) -3-r-3-cephem-4-carboxyliques, leur procede de preparation et leur application en tant que medicaments | |
FR2341584A1 (fr) | Nouveaux derives de thienothiazine, leur procede de preparation et leur application en tant que medicaments | |
BE862275A (fr) | Nouveaux acides sulfamoylbenzoiques, leur preparatrion et leur application en tant que medicaments | |
FR2292472A1 (fr) | Nouveaux derives d'isoindole utiles en tant que medicaments, et leur procede de preparation | |
FR2275215A1 (fr) | Nouveaux derives heterocycliques de desacetoxycephalosporine, procede pour leur preparation et application en tant que medicament | |
FR2315260A1 (fr) | Nouveaux composes araliphatiques dihalogenes, leur application en tant que medicaments et leur procede de preparation | |
FR2318644A1 (fr) | Nouveaux fluoteroides, leur application en tant que medicaments et leur procede de preparation | |
FR2351994A1 (fr) | Composes 9-(5-o-acyl-b-d-arabinofuranosyl)-adeniniques, procede pour leur preparation et application en tant que medicaments | |
FR2314709A1 (fr) | Nouveaux derives alcyniques, leur procede de preparation et leur application en tant que medicaments | |
FR2309217A1 (fr) | Nouveaux phenylalcanols, leur application en tant que medicaments et leur procede de preparation | |
BE864290A (fr) | Nouveaux aryl-hexafuranosides, leur preparation et leur application en tant que medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse | ||
AM | Act modifying the rights related to an application or a patent | ||
TP | Transmission of property |